Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)

Last updated: June 11, 2016
Sponsor: National Nutrition and Food Technology Institute
Overall Status: Trial Status Unknown

Phase

2/3

Condition

Panic Disorders

Anxiety Disorders

Mood Disorders

Treatment

N/A

Clinical Study ID

NCT02800733
450/3654
  • Ages 18-55
  • All Genders

Study Summary

anxiety disorder is one of the major public health problems worldwide. 25% of people experience anxiety disorders throughout life. Generalized anxiety disorder (GAD) is known as the most prevalent anxiety disorder. Saffron has previously approved as an effective adjuvant therapy in depression and might alleviate GAD symptoms.Since up to the best of our knowledge no human studies have assessed the therapeutic effect of saffron as an adjuvant therapy in GAD patients, Therefore, this study is planned to evaluateThe effect of saffron (Crocus satious L.) in the treatment of mild to moderate generalized anxiety disorder:

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients who diagnosed with GAD according to DSM-V criteria, Hamilton score of 18-25

Exclusion

Exclusion Criteria:

  • pregnancy and lactation

  • receiving antipsychotic medications in a month prior to the recruitment

  • suffered from other psychological disorders (e.g. bipolar disorder, schizophrenia,mood disorders), and drug abuse

Study Design

Total Participants: 40
Study Start date:
June 01, 2016
Estimated Completion Date:
September 30, 2016